For further details see:
BELLUS Health, aTyr Pharma leads healthcare gainers; Virpax Pharmaceuticals, RedHill Biopharma among major losersFor further details see:
BELLUS Health, aTyr Pharma leads healthcare gainers; Virpax Pharmaceuticals, RedHill Biopharma among major losersMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Virpax Pharmaceuticals Inc. Company Name:
VRPX Stock Symbol:
Market:
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indicat...
2024-02-29 08:02:11 ET Virpax Pharmaceuticals Inc (VRPX) announced stock split at a ratio of 1-for-10 on 2024-03-01 ... Full story available on KlickAnalytics.com